Citius Oncology launches Lymphir treatment for rare lymphomaBy jay.trebleDecember 3, 2025Listen to this article Citius Oncology Inc. has commercially launched Lymphir, a treatment for Stage I–III cutaneous T-cell lymphoma, the Cranford-based firm announced Dec. 1. In…
3
4
5
